Jain Global’s Integra LifeSciences IART Stock Holding History

Jain Global’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-24,624	Closed	-$302K	–	1246
2025 Q2	$302K	Buy	+24,624	New	+$358K	﹤0.01%	889

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jain Global's IART Position: Q3 2025 in Review

Jain Global sold out of Integra LifeSciences (IART) in Q3 2025, closing a stake of 24,624 shares — an estimated $302K sold.

Jain Global first reported a position in IART in Q2 2025 and held it in 1 quarter. The position peaked at $302K in Q2 2025. 207 funds tracked by Wall St. Rank hold IART as of Q3 2025.

Jain Global reported no remaining Integra LifeSciences position as of Q3 2025 after selling out during the quarter.
Jain Global sold 24,624 Integra LifeSciences shares in Q3 2025, an estimated $302K.
Jain Global first reported a position in Integra LifeSciences in Q2 2025 and held it in 1 quarter.
Jain Global's Integra LifeSciences position peaked at $302K in Q2 2025.
207 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.